Zenalux technology has been applied to the quantitative optical analysis of tissues in a number of published studies in both pre-clinical models and in patients. In the breast, the Zenalux technology has been proven to be sensitive to sources of intrinsic optical contrast, in particular, hemoglobin, beta carotene and scattering which effectively discriminate diseased from healthy tissues (see Published Papers.)